drugset / Trial / NCT02022254
Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects
CrossoverOpen-labelTreatment
Summary
This trial is conducted in Europe and Asia. The aim of the trial is to investigate the influence of semaglutide on pharmacokinetics (the exposure of the trial drug in the body) and pharmacodynamics (the effect of the investigated drug on the body) of warfarin and pharmacokinetics of metformin in healthy subjects.
Timeline
- Start
- 2013-12-17
- Primary completion
- 2014-08-28
- Completion
- 2014-08-28
Outcome
Met primary endpoint
paper Estimated area under the plasma concentration-time curve ratios for all concomitant medications before and with semaglutide treatment were within the pre-specified interval. PMID 28349387 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 500 mg | Oral |
| Subject | Semaglutide | Peptide | 1 mg | Subcutaneous |
| Subject | Warfarin | Small molecule | 25 mg | Oral |